K. Antoniou (Heraklion, Greece), M. Vasakova (Prague, Czech Republic)
LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study
S. Harari, V. Giunta, C. Albera, C. Vancheri, V. Poletti, A. Pesci, F. Luppi, C. Saltini, C. Agostini, P. Rottoli, A. Sebastiani, A. Sanduzzi, A. Caminati, R. Della Porta, G. P. Bandelli, S. Puglisi, S. Tomassetti, A. Biffi, C. Stefania, A. Mari, F. Cinetto, F. Tirelli, G. Farinelli, M. Bocchino, M. Confalonieri (Milan, Turin, Catania, Forlì, Monza, Modena, Roma, Padua, Siena, Naples, Trieste, Italy)
|   |
A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
S. Hashimoto, Y. Taguchi, T. Hajiro, I. Yasuda, Y. Ishii, M. Ebina, K. Kishi, H. Taniguchi, T. Suda, S. Homma, Y. Sugiyama (Tenri, Shimotsuga-gun, Sendai, Minato, Seto, Hamamatsu, Ota, Shimotsuke, Japan)
| |
Prognostic significance of asymmetrical distribution of opacities on high-resolution computed tomography in acute exacerbation of interstitial pneumonia
A. Sokai, K. Tanizawa, T. Handa, T. Kubo, K. Ikezoe, Y. Nakatsuka, K. Aihara, S. Nagai, T. Hirai, K. Chin, M. Mishima (Kyoto, Osaka, Japan)
|  |
Effect of design modifications on trial outcomes in idiopathic pulmonary fibrosis (IPF): Analysis of data from ASCEND and CAPACITY (CAP)
T. King, W. Bradford, S. Castro-Bernardini, E. Fagan, I. Glaspole, M. Glassberg, E. Gorina, P. Hopkins, D. Kardatzke, L. Lancaster, D. Lederer, S. Nathan, C. Pereira, S. Sahn, R. Sussman, J. Swigris, P. Noble (San Francisco, Brisbane, Miami, Nashville, New York, Falls Church, Charleston, Summit, Denver, Los Angeles, United States Of America; Lima, Peru; Melbourne, Brisbane, Australia; Sao Paolo, Brazil)
| |
Titel: MicroRNA analysis in Epithelial Lining Fluid (ELF) compared to Bronchoalveolar Lavage (BAL) in Interstitial pulmonary fibrosis (IPF)
N. Kahn, M. Meister, R. Eberhardt, T. Muley, U. Oltmanns, F. J. F. Herth, M. Kreuter (Heidelberg, Germany)
| |
Retinoic acid-related orphan receptor-a (Rora) expression in patients with fibrotic interstitial pneumonias: A lung tissue study
E. Bibaki, A. Koutsopoulos, E. Tsitoura, E. Lagoudaki, S. Sarantoulaki, I. Lasithiotaki, N. Siafakas, G. Sourvinos, K. Antoniou (Heraklion, Greece)
| |
HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders
J. Xu, W. Wang, Q. Luo, R. C. Chen (Guangzhou, China)
| |
Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias
M. Tajiri, M. Okamoto, K. Fujimoto, J. Takeshi, T. Kawayama, S. Ohta, K. Izuhara, T. Hoshino (Kurume, Itami, Saga, Japan)
| |